Postoperative pain at 48 hours VAS from 0 to 10 · women with uterine fibroids
1 finding from 1 review
Perioperative in‐hospital adverse events; unscheduled return to theatre · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; unscheduled return to… compared with open myomectomy (all types) (low certainty).
1 finding from 1 review
Perioperative in‐hospital adverse events; laparoconversion · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; laparoconversion compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
Perioperative in‐hospital adverse events; injury to pelvic organs · women with uterine fibroids
Laparoscopic myomectomy showed no clear difference in perioperative in‐hospital adverse events; injury to pelvic organs compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
In‐hospital adverse events; postoperative fever · women with uterine fibroids
Laparoscopic myomectomy probably leads to lower in‐hospital adverse events; postoperative fever compared with open myomectomy (all types) (moderate certainty).
1 finding from 1 review
Disease-free survival · people with Rectal Cancer
Laparoscopic showed no clear difference in disease‐free survival at 5 years compared with open total mesorectal excision (moderate certainty).
1 finding from 1 review
Overall survival at 5 years · people with Rectal Cancer
Laparoscopic showed no clear difference in overall survival at 5 years compared with open total mesorectal excision (moderate certainty).
1 finding from 1 review
Local recurrence · people with Rectal Cancer
Laparoscopic showed no clear difference in local recurrences compared with open total mesorectal excision (moderate certainty).
1 finding from 1 review
Lymph nodes retrieved · people with Rectal Cancer
1 finding from 1 review
CRM positivity · people with Rectal Cancer
Laparoscopic showed no clear difference in CRM positivity compared with open total mesorectal excision (moderate certainty).
1 finding from 1 review
Total morbidity · people with Rectal Cancer
Laparoscopic showed no clear difference in 30‐day morbidity (total) compared with open total mesorectal excision (moderate certainty).
1 finding from 1 review
Length of hospital stay · people with Rectal Cancer
1 finding from 1 review
Reduction of snoring · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
The review found no eligible studies for this question.
1 finding from 1 review
Position of the incisors (upper incisor inclination) · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
1 finding from 1 review
The author reported that data (1.NA, 1-NA, 1-PP, 1.NB, 1-NB, 1-GoMe) showed a statistically significant difference. There was palatal inclination of the upper incisors in the intervention group that contributed to…
1 study
GRADE not reported
Side effects / tolerability · Children and adolescents (over 80% aged 16 years or younger at treatment start) with anterior open bite (lack of vertical overlap or…
The review found no eligible studies for this question.
1 finding from 1 review
All cause mortality · people with cancer who have febrile neutropenia
beta‐lactam monotherapy showed no clear difference in all cause mortality compared with beta‐lactam‐aminoglycoside combination therapy (high certainty).
1 finding from 1 review
Any nephrotoxicity ‐ Ag dosing regimen (Copy) · people with cancer who have febrile neutropenia
beta‐lactam monotherapy leads to lower any nephrotoxicity ‐ Ag dosing regimen (Copy) compared with beta‐lactam‐aminoglycoside combination therapy (high certainty).
1 finding from 1 review
Clinical failure—same beta lactam Antibiotic modifications · people with cancer who have febrile neutropenia
beta‐lactam monotherapy probably leads to higher treatment failure ‐ same beta‐lactam compared with beta‐lactam‐aminoglycoside combination therapy (moderate certainty).
1 finding from 1 review
Treatment failure ‐ different beta‐lactam · people with cancer who have febrile neutropenia
beta‐lactam monotherapy may leads to lower treatment failure ‐ different beta‐lactam compared with beta‐lactam‐aminoglycoside combination therapy (low certainty).
1 finding from 1 review
All‐cause mortality · people with cancer who have febrile neutropenia
Oral showed no clear difference in mortality compared with intravenous antibiotic therapy (moderate certainty).
1 finding from 1 review